CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
40.71
+2.71 (7.13%)
At close: Oct 8, 2025, 4:00 PM EDT
41.29
+0.58 (1.42%)
After-hours: Oct 8, 2025, 7:45 PM EDT

CG Oncology Stock Forecast

Stock Price Forecast

The 12 analysts that cover CG Oncology stock have a consensus rating of "Strong Buy" and an average price target of $66.83, which forecasts a 64.16% increase in the stock price over the next year. The lowest target is $47 and the highest is $90.

Price Target: $66.83 (+64.16%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$47$66.83$75$90
Change+15.45%+64.16%+84.23%+121.08%

Analyst Ratings

The average analyst rating for CG Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy666677
Buy445666
Hold000000
Sell000000
Strong Sell000000
Total101011121313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Guggenheim
Guggenheim
Strong Buy
Initiates
$90
Strong BuyInitiates$90+121.08%Oct 8, 2025
JP Morgan
JP Morgan
Buy
Maintains
$41$47
BuyMaintains$41$47+15.45%Sep 26, 2025
Morgan Stanley
Morgan Stanley
Buy
Maintains
$56$79
BuyMaintains$56$79+94.06%Sep 17, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$75
Strong BuyReiterates$75+84.23%Sep 15, 2025
Jones Trading
Jones Trading
Strong Buy
Initiates
$50
Strong BuyInitiates$50+22.82%Sep 8, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
256.16K
from 1.14M
Decreased by -77.51%
Revenue Next Year
89.30M
from 256.16K
Increased by 34,759.86%
EPS This Year
-2.20
from -1.41
EPS Next Year
-2.31
from -2.20
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
10.36M191.00K204.00K1.14M256.16K89.30M185.42M
Revenue Growth
--98.16%6.81%458.33%-77.51%34,759.86%107.64%
EPS
-5.04-11.71-15.65-1.41-2.20-2.31-1.77
EPS Growth
-------
Forward PE
-------
No. Analysts
----141410
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High1.4M268.6M
Avg256,16389.3M
Lown/a10.3M

Revenue Growth

Revenue Growth20252026202720282029
High
19.8%
104,735.7%
Avg
-77.5%
34,759.9%
Low-
3,917.0%

EPS Forecast

EPS20252026202720282029
High-2.01-0.95
Avg-2.20-2.31
Low-2.25-3.72

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.